COHEN RON (President and CEO) sold 1.7% of their position (2.29K shares) of ACORDA THERAPEUTICS, INC. on the open market
Open‑market sale worth $3.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/21/2022ACC: 0001209191-22-020260
DirectorOfficer· President and CEO
Since Sep 2018
-2.29K
Net shares
Net seller
$3.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.29K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.29K
Price / share
$1.70
Trade value
$3.89K
% of position
1.7%
3/17/2022
131.89K→129.60K
Total
Net shares
−2.29K
Net value
-$3.89K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/17/2022 | S · Sale | −2.29K | $1.70 | $3.89K | 1.7% | 131.89K | 129.60K |
| Total | −2.29K | -$3.89K | ||||||
Derivative Transactions0
No derivative transactions reported